ClinVar Miner

Submissions for variant NM_000021.4(PSEN1):c.338T>C (p.Leu113Pro)

dbSNP: rs63751399
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics Inc RCV000084292 SCV001145224 likely pathogenic not provided 2019-04-04 criteria provided, single submitter clinical testing Not found in the total gnomAD dataset, and the data is high quality (0/282660 chr). Found in at least one symptomatic patient. Predicted to have a damaging effect on the protein. Damaging to protein function(s) relevant to disease mechanism.
Invitae RCV001228362 SCV001400758 likely pathogenic Alzheimer disease 3; Frontotemporal dementia; Pick disease; Acne inversa, familial, 3 2019-10-16 criteria provided, single submitter clinical testing In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Leu113 amino acid residue in PSEN1. Other variant(s) that disrupt this residue have been observed in individuals with PSEN1-related conditions (PMID: 15776278), which suggests that this may be a clinically significant amino acid residue. This variant has been reported not to substantially affect PSEN1 protein function (PMID: 17431506, 20634584). This variant has been observed in an individual and a family affected with clinical features of early-onset Alzheimer's disease (PMID: 11094121, Invitae). This gene is also known as PS1 in the literature. ClinVar contains an entry for this variant (Variation ID: 18145). This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with proline at codon 113 of the PSEN1 protein (p.Leu113Pro). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and proline.
OMIM RCV000019775 SCV000040073 pathogenic Frontotemporal dementia 2000-11-28 no assertion criteria provided literature only
GeneReviews RCV000020084 SCV000040384 not provided Alzheimer disease 3 no assertion provided literature only
VIB Department of Molecular Genetics, University of Antwerp RCV000084292 SCV000116428 not provided not provided no assertion provided not provided

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.